A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    
Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Buclizine, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Buclizine impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Buclizine-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.

Buclizine Related Compounds

Stable Isotopes

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Buclizine-d8 Dihydrochloride Stable Isotopes CS-O-06448 129-74-8(Unlabeled) In Stock
Buclizine 13C6 Stable Isotopes CS-EK-01950 82-95-1 unlabeled Enquire


API

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Buclizine Dihydrochloride API CS-O-03935 129-74-8 In Stock
Buclizine API CS-P-00366 82-95-1 Enquire


Impurity

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Cetirizine EP Impurity A Impurity CS-O-31588 303-26-4 In Stock


Intermediate

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
4-Chlorobenzophenone Intermediate CS-O-07596 134-85-0 In Stock